Related by context. All words. (Click for frequent words.) 72 related Macular Degeneration 70 toenail onychomycosis 70 diabetic macular edema DME 70 kidney urologic 70 choroidal neovascularization 69 Neovascular AMD 69 INSPIRE Trial Phase III 69 predominantly classic subfoveal 69 PLX STROKE targeting 69 AMD diabetic retinopathy 68 Bayer HealthCare Onyx Pharmaceuticals 68 treat neovascular wet 68 neovascular wet age 68 CIMZIA R 67 CIMZIA r certolizumab pegol 67 Central Retinal Vein 67 psoriasis vulgaris 67 constipation OIC 67 acetonide FA 67 macular edema secondary 67 severe ocular allergies 67 prematurity Stargardt disease 67 CYT# potent vascular disrupting 67 retinal vein occlusion induced 67 relapsed MM 67 humanized therapeutic 67 neovascular age 66 common neurovascular complication 66 neovascular 66 aMCI precursor 66 reduce serum phosphate 66 presumed ocular histoplasmosis 66 syndrome gastroesophageal reflux 66 psoriatic arthritis PsA 66 induced macular edema 66 albiglutide currently 66 glaucoma diabetic retinopathy 66 Alzheimer disease cognitive impairment 66 neuropathic pain spasticity 66 CTAP# 66 Evoltra ® 66 rheumatoid arthritis psoriatic arthritis 66 occlusion CRVO 66 geographic atrophy 65 Ribavirin causes 65 somatostatin analog 65 delivers fluocinolone acetonide FA 65 prokinetic agent 65 EVIZON ™ 65 dyslipidemia hypertension diabetes 65 Nonalcoholic fatty liver 65 Hypoactive Sexual Desire Disorder 65 recurrent malignant glioma 65 Vitrasert R 65 autoantibody positive 65 choroidal neovascularisation 65 Ostabolin C TM 65 brand ciclesonide HFA 65 vitreous floaters 65 membranous nephritis 65 LymphoStat B belimumab 65 photodynamic therapies 65 Neovascular 65 Crofelemer budesonide foam 65 Testosterone MDTS R 65 inflammation metabolic disorders 65 cognitive impairment associated 65 decompensated liver disease 65 Atopic eczema 65 hyperphenylalaninemia HPA due 65 Perceiva 65 C1 INH deficiency 65 Ophena TM 65 ATRA IV 64 rheumatoid arthritis inflammatory bowel 64 Heterozygous Familial Hypercholesterolemia 64 exudative 64 Budesonide foam crofelemer 64 pralatrexate injection folate analogue 64 IMiDs ® 64 chronic thromboembolic pulmonary 64 RhuDex ™ 64 histologically active 64 mild renal insufficiency 64 choroidal neovascularization CNV 64 alpha1 antitrypsin deficiency 64 vapreotide acetate 64 TTR amyloidosis 64 Testosterone deficiency 64 catheter occlusion 64 either acutely decompensated 64 Frozen Shoulder syndrome Adhesive 64 Neovascular Age Related Macular 64 neovascular diseases 64 pathologic myopia 64 receiving XGEVA 64 epilepsy Parkinson disease 64 PresbyLens ® 64 VEGFR2 inhibitor 64 Diabetic macular edema 64 myocardial infarction ventricular fibrillation 64 neurodegenerative disorder characterized 64 iSONEP TM 64 ospemifene 64 Degeneration AMD 64 pegaptanib 64 desvenlafaxine succinate 64 unresectable tumors 64 rheumatoid arthritis osteoarthritis ankylosing 64 Diabetic Macular Edema 64 cutaneous lupus 64 rhIGF-I/rhIGFBP-3 63 ocular angiogenesis 63 de novo AML 63 diabetic retinopathy DR 63 osteolytic bone disease 63 opioid naive 63 Anti VEGF 63 OMNARIS HFA 63 octreotide implant 63 Stargardt Macular Dystrophy 63 thetreatment 63 onset idiopathic hypogonadism 63 Syncria R 63 essential thrombocythemia ET 63 hyperplasia BPH 63 CIMZIA TM certolizumab pegol 63 EVIZON TM 63 relapsing remitting MS RRMS 63 proliferative retinopathy 63 dyslipidemia abnormal 63 FUSILEV enhances 63 related maculopathy 63 headache nasopharyngitis 63 ocular inflammatory 63 non splenectomized 63 Wet AMD 63 GERD migraine headaches 63 dilated cardiomyopathy DCM 63 MAGE A3 ASCI 63 systemic juvenile idiopathic 63 patientswith 63 Systemic Sclerosis 63 pulmonary hypertension PH 63 nasopharyngitis headache 63 diarrhea predominant irritable 63 insomnia somnolence 63 By JENNIFER LEARN 63 chronic idiopathic urticaria 63 PsA 63 Aeolus Pharmaceuticals Announces 63 HIV HCV coinfected 63 demonstrated antitumor activity 63 Acne vulgaris 63 Mg Uk 63 concomitant cardiac 63 Acute Exacerbations 63 oropharyngeal candidiasis OPC 63 Kuvan sapropterin dihydrochloride 63 Uncontrolled hypertension 63 deCODE Glaucoma TM 63 use transdermal sumatriptan 63 Acute Bacterial Sinusitis ABS 63 evaluating mipomersen 63 Diabetic Macular Edema DME 63 glucocorticoid induced osteoporosis 63 severely active polyarticular 63 Juvenile Idiopathic Arthritis 63 castrate resistant prostate cancer 63 ANCA associated 63 ACTEMRA TM 62 R Saizen R 62 Aryplase 62 primary dysmenorrhea 62 Retisert ® 62 BCG refractory carcinoma 62 CRVO 62 deCODE ProstateCancer TM 62 Stargardt Macular Dystrophy SMD 62 treatment naive genotype 62 schizophrenia CIAS 62 severe hepatic dysfunction 62 mitoxantrone plus 62 intravitreal insert 62 treat chronic sinusitis 62 NB S# strontium malonate 62 chronic myeloid 62 Callisto initiated 62 recurrent glioblastoma multiforme 62 Empatic ™ 62 asthma rheumatoid arthritis 62 formerly LymphoStat B 62 GH deficiency 62 Amgen Neulasta R 62 Diabetic Retinopathy DR 62 delta gamma agonist 62 central retinal vein 62 Squalamine 62 post herpetic 62 antiretroviral naïve 62 MTP inhibitor 62 O PPDS 62 erythema nodosum 62 sorafenib tablets 62 vaginal candidiasis 62 expanded autologous cellular 62 Surfactant Replacement Therapies SRT 62 EVIZON TM squalamine lactate 62 psoriasis psoriatic arthritis 62 reversible obstructive airway 62 AA Amyloidosis 62 juvenile idiopathic arthritis 62 inflammatory acne 62 CP CPPS 62 metastatic renal 62 relapsed leukemia 62 treat musculoskeletal metabolic 62 venlafaxine XR 62 topical gel formulation 62 AFREZZA TM 62 retinal vein occlusion RVO 62 fusion enhancers 62 pediatric Crohn disease 62 syndrome overactive bladder 62 complement inhibitor eculizumab 62 Alzheimer disease vascular dementia 62 esophageal candidiasis 62 cystic fibrosis allergic rhinitis 62 Relapsing remitting MS 62 cause mesothelioma asbestosis 62 advanced medullary thyroid 62 relapsed mantle 62 Systemic lupus erythematosus SLE 62 chronic periodontitis 62 acute mania 62 Dupuytren Disease 62 intravenous RSD# 62 Provectus Pharmaceuticals specializes 62 personalized cellular immunotherapy 62 AKT inhibitor 62 oral dihydropyrimidine dehydrogenase DPD 62 myopic macular degeneration 62 primary generalized tonic 62 coronary stent merged 62 RTP #i 62 HIV coinfected 62 immunocompetent adults 62 PI3K/Akt pathway inhibitor 62 including acne photodamage 62 Ranibizumab 62 secondary hyperparathyroidism 62 Tectin TM 62 novel VDA molecule 62 TRIOLEX HE# APOPTONE HE# 62 chronic progressive neurodegenerative 62 receiving chemoradiation therapy 62 atypical Hemolytic Uremic Syndrome 62 progressive PsA 62 oral anti arrhythmic 62 Initiates Clinical Trial 62 evaluate ZFP Therapeutic 61 myelodysplastic myeloproliferative diseases 61 Primary IGFD 61 JAK2 Inhibitor 61 acyclovir Lauriad R 61 onset diabetes mellitus 61 pharmacogenomic translational research 61 non cirrhotic portal 61 Hsp# Inhibitor 61 retinal thrombosis hemorrhages 61 novel therapeutic antibodies 61 CYP#A# CYP#D# 61 systemic anaplastic large 61 Non Alcoholic Steatohepatitis 61 iSONEP ™ 61 benign prostatic hypertrophy BPH 61 biliary tract cancer 61 Bronchiectasis 61 Age Related Macular 61 APEX PD 61 ophthalmologic disorders 61 diabetic kidney 61 Dementia Related Psychosis 61 undergoing elective percutaneous 61 LUCENTIS 61 LHRH receptor positive 61 hypertension cardiovascular disease 61 Dosa suffers 61 Aortic stenosis 61 hepatorenal syndrome 61 GRNOPC1 contains 61 LAB CGRP 61 Phase Ib IIa 61 systemic autoimmune 61 weekly subcutaneous injections 61 progressive neurodegenerative 61 metastatic colorectal carcinoma 61 cryosurgical treatment 61 refractory chronic lymphocytic 61 orally inhaled migraine 61 diabetic macular edema 61 oral ghrelin agonist 61 recurrent glioma 61 infliximab monotherapy 61 de novo kidney transplant 61 Temodar ® 61 AAG geldanamycin analog 61 albiglutide 61 developing Bicifadine serotonin 61 Leber Congenital Amaurosis LCA 61 relapsing multiple sclerosis 61 unresectable recurrent 61 AVAPRO 61 monitoring disposables endosurgery 61 Silodosin 61 overt nephropathy 61 INS# [001] 61 haematologic 61 noninfectious uveitis 61 interferon gamma 1b 61 TELINTRA R 61 commercialize deforolimus 61 oral JAK#/JAK# inhibitor 61 oral sapacitabine 61 idiopathic thrombocytopenic purpura 61 Elestrin ® 61 approved incretin mimetic 61 novel oral anticoagulant 61 Oral NKTR 61 Hedgehog Pathway Inhibitor 61 papillary renal cell carcinoma 61 collagen vascular 61 neutropenia dehydration dyspnea 61 involuntary dyskinetic movements 61 Severe Primary IGFD 61 chronic rheumatic 61 choroidal vasculopathy 61 myelofibrosis polycythemia vera 61 primary immunodeficiency PI 61 nonmelanoma 61 recurrent metastatic ovarian cancer 61 vascular occlusive diseases 61 Atypical Hemolytic Uremic Syndrome 61 Liprotamase 61 dermatologic reactions 61 systemic invasive fungal 61 hyaluronidase enzyme 61 metastatic gastric 61 gastroenterology neurology 61 treating sarcoma testicular 61 retinal transplantation 61 convulsive disorders 61 Safinamide 61 neurogenic bladder 61 pain palliation 61 Atopic dermatitis 61 recombinant PSMA vaccine 61 multi infarct dementia 61 RSD# oral 61 dermatologic diseases 61 leukemia multiple myeloma 61 CINQUIL 61 Orthostatic hypotension 61 Acute Coronary Syndromes ACS 61 hypereosinophilic syndrome 61 Intravitreal injections 61 recurrent genital herpes 61 AVN# Phase 61 NS5B polymerase 61 herpetic keratitis 61 NASH Huntington 61 XSSE OXGN 61 asthma rhinitis 61 infectious diseases autoimmune diseases 61 trauma malignant tumors 60 interferon alpha IFN 60 infection epistaxis dyspnea exfoliative 60 treatment naïve genotype 60 aflibercept VEGF Trap 60 gastrointestinal disorders ATI 60 RhuDex R 60 Major Depressive Disorder MDD 60 metastatic lesions involving 60 vidofludimus 60 lintuzumab SGN 60 Accelerating apoptosis may 60 peripheral arterial occlusive disease 60 candidates Azedra TM 60 Mg Usa 60 Acute myeloid leukemia 60 IMPDH inhibitor 60 Tasimelteon 60 hoFH 60 cladribine Cladribine Tablets 60 REMURA 60 autoimmune uveitis 60 venous stasis ulcers 60 Naive Patients 60 Optiquel ™ 60 pouchitis 60 fistulizing CD 60 Synovial sarcoma 60 blinded randomized placebo controlled 60 atypical hemolytic uremic syndrome 60 manufactures minimally invasive 60 vWD 60 indolent follicular non 60 asthma emphysema bronchitis 60 Chronic ITP 60 diabetic retinopathy glaucoma 60 tramiprosate Alzhemed TM 60 Syncria albiglutide 60 late onset Pompe 60 structure infections ABSSSI 60 active ankylosing spondylitis 60 EVIZON 60 conjunctival hyperemia 60 AML MDS 60 glaucoma ischemia 60 Prodarsan R 60 psoriasis vitiligo atopic dermatitis 60 animist Hindu 60 congenital deficiency 60 small molecule Hedgehog 60 OHR/AVR# 60 atherosclerotic vascular disease 60 Meets Primary Endpoint 60 PKU genetic 60 inhalant addiction 60 Implantable lenses 60 Completes Patient Enrollment 60 immunocompetent patients 60 High Dose quadruples 60 metaglidasen 60 pharmacologically active isomer 60 chronic idiopathic thrombocytopenic purpura 60 lymphomas leukemias 60 damage cirrhosis liver 60 retinal degenerations 60 psychiatric disorders neurological 60 Lennox Gastaut syndrome 60 FOLOTYN ® 60 BRIM2 60 headache abdominal pain 60 AGILECT R 60 CTAP# Capsules 60 EnteroMedics proprietary neuroblocking technology 60 Initiates Enrollment 60 Selzentry Celsentri 60 Sirtex SIR Spheres microspheres 60 BENLYSTA TM 60 lymphoid malignancies 60 stage IIIb IV 60 8mg/kg 60 overactive bladder syndrome 60 Infusion Reactions Severe 60 Postherpetic neuralgia PHN 60 nasal calcitonin product 60 morphometric vertebral fractures 60 symptomatic BPH 60 LHON 60 Prednisone Against Refractory 60 acne vulgaris 60 hereditary emphysema 60 dependent kinase inhibitor 60 humanized interleukin 6 60 Teriflunomide 60 arthritis PsA 60 R lenalidomide 60 refractory colorectal cancer 60 oral beclomethasone dipropionate 60 post herpetic neuralgia PHN 60 overt hepatic encephalopathy HE 60 wet exudative 60 naïve HCV 60 juvenile myoclonic epilepsy 60 HeFH 60 Sezary syndrome 60 psoriasis Crohn disease 60 selective phosphodiesterase 60 IMiDs R 60 lumbar spinal stenosis LSS 60 modified glutathione analog 60 biologic DMARD 60 deCODE AF TM 60 serologically active systemic lupus 60 hypertension hypercholesterolemia 60 CC genotype 60 Benign Prostatic Hyperplasia BPH 60 Shellgel TM injectable viscoelastic 60 relapsed refractory AML 60 thalassemia sickle cell 60 TÎ ² 4 60 castration resistant hormone refractory 60 SIADH 60 unique alkylating agent 60 R sorafenib tablets 60 Phase III multicenter 60 refractory metastatic 60 smoldering myeloma 60 pathological hallmark 60 R roscovitine 60 pathological hallmarks 60 Diabetic Retinopathy 60 Chronic lymphocytic leukemia 60 Primary Hypercholesterolemia 60 NSAID associated 60 related CMV Retinitis 60 oral picoplatin 60 orally administered inhibitor 60 Initiates Phase II 60 minimally symptomatic 60 Cardium Therapeutics TM 60 Deforolimus 60 Clot Busting 60 branch retinal vein 60 multicenter Phase III 60 gastrointestinal GI motility disorders 60 Rheumatoid Arthritis RA 60 diagnosed Ph + 60 amnestic mild cognitive impairment 60 ® lenalidomide 60 Systemic lupus 60 diseases osteoarthritis osteoporosis 60 M# rationally 60 psoriasis inflammatory bowel 60 Study AREDS 60 Gastro intestinal 60 metastatic bladder 60 randomized controlled multicenter 60 neurosensory 60 MKC# 59 Sudhir Agrawal D.Phil 59 Aflibercept 59 respiratory allergy dermatological 59 Lennox Gastaut Syndrome 59 Zenvia ™ 59 clonidine hydrochloride 59 Myelodysplastic Syndrome MDS 59 via intradermal injections 59 Investigational Treatment 59 pancreatic insufficiency 59 Refractory Hodgkin Lymphoma 59 investigational atypical antipsychotic 59 HDL Selective Delipidation 59 included neutropenia anemia 59 Combivir Kivexa 59 class mGluR5 inhibitor 59 includes Dideco CarboMedics 59 advanced metastatic renal 59 IBS C 59 adjuvant systemic 59 obstructive sleep apnea hypopnea 59 deep venous thromboses 59 Chemotherapy induced 59 benign prostatic hyperplasia enlarged 59 SPRYCEL ® 59 primary hypercholesterolemia 59 developing Surfactant Therapies 59 moderate renal impairment 59 HCV RNA polymerase 59 opioid induced bowel dysfunction 59 progressive neurodegenerative disorder 59 MKC# MT 59 immune thrombocytopenic purpura 59 CTEPH 59 GI motility disorders 59 Prospective Randomized 59 Diabetic nephropathy 59 multifactorial disease 59 oral rehydration IV 59 hypertension pulmonary arterial 59 nephropathic cystinosis cystinosis 59 D aspartate NMDA receptor 59 methylnaltrexone bromide 59 unresectable malignant mesothelioma UMM 59 Bronchopulmonary Dysplasia 59 chronic immune thrombocytopenic 59 poststroke depression 59 glaucoma cataract 59 hypertension osteoarthritis 59 Services #:#-#,# Abstract 59 hay fever allergic rhinitis 59 diabetic neuropathic pain 59 GATTEX ™ 59 gastrointestinal stromal 59 LPLD 59 HBeAg negative 59 neuropathic pain metabolic diseases 59 Lipodystrophy 59 randomized #:#:# 59 treat secondary hyperparathyroidism 59 NOMID 59 Pyridorin 59 squalamine 59 subfoveal choroidal neovascularization 59 macular disease 59 severe malignant osteopetrosis 59 Veronate R 59 Ankylosing spondylitis 59 Systemic lupus erythematosus 59 Bystolic nebivolol 59 mixed hyperlipidemia 59 subependymal giant cell 59 inflammatory demyelinating 59 chronic renal disease 59 maximally tolerated lipid lowering 59 galiximab 59 inflammation thrombosis oncology 59 macroalbuminuria 59 Keratitis 59 commercializes innovative biopharmaceuticals 59 DNA methyltransferase inhibitors 59 Meningiomas usually occur 59 orthopedics pediatrics 59 included exfoliative dermatitis 59 Bucindolol 59 cause cardiac channelopathies 59 neurological manifestations 59 MetroGel 59 CEL SCI Phase III 59 acute myeloid 59 Phase III Pivotal 59 sapropterin dihydrochloride Tablets 59 Temsirolimus 59 non constipating irritable 59 Chronic Idiopathic Constipation 59 Macular edema 59 atrial fibrillation budiodarone ATI 59 jeanswear outerwear packs 59 unresectable stage 59 Associated Adipose Redistribution 59 AzaSite ISV 59 Nasdaq MNKD focused 59 Capsulitis 59 riociguat 59 Hypertrophy 59 atopic asthma 59 ALN VSP Phase 59 Begins Dosing 59 PD LID 59 spleen enlargement 59 HA viscoelastic products 59 rheumatologic 59 Slows Progression 59 eosinophilic asthma 59 neovascular AMD 59 diffuse gastric 59 isolated systolic hypertension 59 Neovascularization 59 registrational Phase 59 Xanafide 59 Thiazolidinediones 59 receiving VELCADE 59 alpha1 antitrypsin AAT deficiency 59 Myolimus 59 neuropsychiatric disorder 59 ENL recurrence 59 AGHD 59 MKC# MKC# PP 59 Nothing Wadden 59 diarrhea headache nausea 59 PEGylated Fab fragment 59 Aggrastat ® tirofiban hydrochloride 59 NYHA Class II 59 systemic sclerosis SSc 59 juvenile idiopathic arthritis JIA 59 Geographic Atrophy 59 Elagolix 59 ovarian endometrial 59 pemphigus vulgaris 59 phase IIb study 59 SNT-MC#/idebenone 59 Raptiva r 59 hypoxia activated prodrug 59 diabetic gastroparesis 59 XL# anticancer compounds 59 paclitaxel poliglumex 59 SHPT 59 Rheos System 59 systemic fungal infections 59 Obstructive sleep apnea OSA 59 synthetic retinoid 59 dyslipidaemia 59 urethral stricture 59 Rindopepimut 59 osteoporotic vertebral compression fractures 59 Alimentary Tract 59 Intravitreal 59 unstable angina UA 59 hour bronchodilation 59 transthyretin amyloidosis 59 constipation predominant irritable bowel 59 REVIVE Diabetes 59 carcinoma mCRC 59 immunologic diseases 59 polymyalgia rheumatica 59 Therapies SRT 59 Tasigna prolongs 59 chronic myocardial ischemia 59 NATRECOR ® 59 psoriasis rheumatoid arthritis 59 diaper dermatitis 59 diabetic retinopathy hyphema glaucoma 59 novel immunotherapies 59 diabetes mellitus DM 59 bone spurs bulging 59 hypercholesterolemia liver 59 Azmacort R 59 Comorbidities 59 GVAX Pancreas Vaccine 59 Myelodysplastic syndromes MDS 59 psychiatric disorders ATI 59 leukemia lymphoma multiple myeloma 59 ALVESCO ® 59 hematological malignancy 59 leukemia AML 59 bullous 59 histologically confirmed 59 diabetic peripheral neuropathic DPN 59 Lucentis ranibizumab 59 parathyroid carcinoma 59 elevated IOP 59 cardiovascular cerebrovascular 59 PrevOnco ™ 59 ocular infections 59 herpes zoster shingles 59 affective psychosis 59 Juvenile Idiopathic Arthritis JIA 59 Multiple Ascending Dose 59 Chronic pancreatitis 59 topically administered 59 chronic obstructive airway 59 prematurity ROP 59 Angiograms carry slight 59 Phase IIA 59 Orally administered 59 6 sulfatase 59 NeuroMove TM 59 developing KL4 surfactant 59 Fibrillex TM 59 fibromyalgia syndrome 59 serum phosphate 59 uremic pruritus 59 topical non steroidal 59 evaluating REVLIMID 59 schizophrenia schizoaffective disorder 59 MACUGEN 59 iobenguane 59 PDE# inhibitors 59 Tolvaptan 59 mildly symptomatic 59 Cutaneous T 59 Warner Chilcott Actonel 59 VICTOR E1 59 VBLOC ™ 59 CCR5 mAb 59 Surgical resection 59 rheumatological 59 Chronic HCV 59 vesicoureteral reflux VUR malformation 59 idiopathic Parkinson disease 59 endocrinology gastroenterology 59 Proellex TM 59 commercializing interventional 59 phase III isavuconazole 59 Sapacitabine 59 left ventricular diastolic 59 VaD 59 Opioid induced bowel dysfunction 59 Unigene nasal calcitonin 59 Warfarin Coumadin 58 vitreoretinal disorders 58 muscular dystrophy cystic fibrosis 58 subcutaneous methylnaltrexone 58 histologic subtype 58 nilotinib Tasigna ® 58 Wet macular degeneration 58 accumulate preferentially 58 eye socket ruptured 58 clinically heterogeneous 58 partial onset seizures 58 nonbacterial prostatitis 58 opioid tolerant adult 58 GAMMAGARD 58 azilsartan medoxomil 58 epilepsy multiple sclerosis 58 DEB# 58 PDE4 modulators 58 TM pralatrexate injection 58 rheumatoid arthritis lupus 58 myeloproliferative neoplasms MPNs 58 abnormal lipids 58 keloid scarring 58 generation purine nucleoside 58 EDEMA3 58 Irritable bowel syndrome IBS 58 Lichen planus 58 INVEGA ® 58 comorbid ADHD 58 acute febrile 58 Chronic lymphocytic leukemia CLL 58 gastro esophageal reflux 58 benign prostatic hypertrophy 58 pre cancerous actinic 58 MGd 58 investigational monoclonal antibody 58 including chloasma melasma 58 TACI Ig 58 refractory acute myeloid 58 quetiapine Seroquel 58 chronic degenerative neurological 58 hypokalemia hypomagnesemia 58 IMiDs ® compound 58 cataracts glaucoma 58 Personalized Immunotherapy 58 Omacetaxine 58 hepatocellular carcinoma liver 58 metastatic hormone refractory 58 serotonin norepinephrine reuptake inhibitor 58 indications Dupuytren 58 NPHP 58 PORxin TM platforms 58 chromosome #q#.# deletion 58 EGFr expressing metastatic colorectal 58 Firdapse TM amifampridine phosphate 58 tumor angiogenesis inhibitors 58 Monoclonal antibody 58 neutropenia thrombocytopenia 58 progressive degenerative neurological 58 urolithiasis 58 Intravenous immunoglobulin 58 Acute Myeloid Leukemia AML 58 intravesical infusion therapy 58 smoldering multiple myeloma 58 acute humoral rejection 58 neuro inflammatory disorders 58 oncology infectious diseases 58 Osteogenesis imperfecta 58 progressive metastatic prostate 58 anorexia nausea vomiting 58 previously untreated follicular 58 lymphoma multiple myeloma 58 Recombinant interferon alpha 58 R ferumoxytol Injection 58 nonalcoholic steatohepatitis 58 Hp2 2 58 Merck KGaA Rebif 58 Routine Paps should 58 Idiopathic pulmonary fibrosis IPF 58 Endologix Powerlink System 58 Major depressive disorder 58 Kit CD# positive 58 common disabling neurological 58 Retisert TM 58 transthyretin mediated amyloidosis ATTR 58 itraconazole Sporanox 58 Leber congenital amaurosis LCA 58 Systemic Juvenile Idiopathic 58 receptor tyrosine kinase inhibitor 58 IMPACT DCM trial 58 SJIA 58 steroid refractory 58 renal kidney 58 Benign prostatic hyperplasia BPH 58 ocular itching associated 58 fungal infections malaria tuberculosis 58 musculoskeletal metabolic 58 cutaneous T 58 novel emulsion formulation 58 mGluR2 positive 58 HER2 positive metastatic 58 GLIADEL Wafer 58 diagnostic molecular imaging 58 primary Restless Legs 58 treating psychiatric disorders 58 rheumatoid arthritis psoriasis 58 Inhaled nitric oxide 58 FOLFOX6 chemotherapy regimen 58 Canvaxin TM 58 disease GERD 58 leukoderma 58 renal failure interstitial lung 58 plaque buildup restricts 58 severe gastroparesis 58 undergoing hematopoietic stem 58 metformin sulfonylurea 58 markets COLAZAL 58 evaluating tivozanib 58 Elizee suffered 58 inflammatory cardio metabolic 58 PAOD 58 lexidronam injection 58 CCR9 antagonist 58 PEGINTRON TM 58 bronchodilatory 58 hypertension diabetes mellitus 58 rALLy clinical trial 58 colorectal adenoma 58 VELCADE melphalan 58 Internists specialize 58 Hyperlipidemia 58 EGFR mutation positive 58 Solzira TM 58 glaucoma macular degeneration 58 Combination REOLYSIN R 58 severe renal impairment 58 Leukemias 58 comorbid disorders 58 proprietary radiolabeled monoclonal 58 Waldenstrom macroglobulinemia 58 Levulan ® PDT 58 lens opacities 58 lenalidomide Revlimid R 58 dapagliflozin plus 58 AIR2 Trial 58 verteporfin 58 myopic CNV 58 PNP inhibitor 58 Syndrome LEMS 58 superficial basal cell carcinoma 58 Boiling kills 58 NP2 Enkephalin 58 including eniluracil ADH 58 defects refraction cataracts 58 cromolyn sodium 58 Prostate enlargement 58 Initiates Dosing 58 dyskinesia PD LID 58 Peginterferon alfa 2b 58 comorbid anxiety 58 Pancreatic insufficiency 58 angiotensin analog 58 iloprost synthetic compound 58 cystic fibrosis chronic pancreatitis 58 Inhalation Aerosol 58 Cimzia TM 58 Wafer polifeprosan 58 acute postoperative 58 potent suppressor 58 myelofibrosis MF 58 chronic opioid 58 photo ablating 58 adult periodontitis 58 Daclizumab 58 familial amyloidotic polyneuropathy FAP 58 Asthma COPD 58 Intervention Effectiveness 58 Thyroid nodules 58 Nephrology Neurology 58 keloid scarring treatment 58 inhalation powder 58 retinal vein occlusion 58 MELAS 58 non hodgkin lymphoma 58 Letairis ambrisentan 58 gastrin analogue TT 58 lupus erythematosus 58 Methylnaltrexone 58 LymphoStat B TM 58 vulvovaginal atrophy 58 prasterone 58 GATTEX ® 58 fosbretabulin 58 Microwave Ablation System 58 dermatological disorders 58 INCB# [003] 58 reactive airways disease 58 stage IIIb 58 childhood disintegrative disorder 58 beta 1a 58 endocrine diseases 58 chronic HCV 58 posterior uveitis 58 dose intramuscular 58 polycythemia vera essential thrombocythemia 58 developing Surfactant Replacement 58 treat lupus renal 58 inappropriate antidiuretic hormone SIADH 58 PR interval prolongation 58 systemic lupus erythematosus rheumatoid 58 Idiopathic pulmonary fibrosis 58 treatmentof 58 gastrointestinal disorders characterized 58 related macular degeneration 58 multicenter Phase II 58 T1DM 58 Pernicious anemia 58 chronic HCV infection 58 hypoparathyroidism 58 Etanercept 58 secondary amenorrhea 58 myeloproliferative disorders 58 prospective multicenter study 58 Xeloda ® 58 oral prodrug 58 efalizumab 58 Attention-Deficit/Hyperactivity Disorder ADHD 58 OvaRex ® MAb